ePRAT: Virtual Management of Rheumatoid Arthritis

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Recruiting
CT.gov ID
NCT05124782
Collaborator
(none)
100
1
11
9.1

Study Details

Study Description

Brief Summary

The purpose of this study is to optimize the care of patients with RA seen in virtual consultation.

Condition or Disease Intervention/Treatment Phase
  • Other: Rheumatoid Arthritis Impact of Disease questionnaire

Detailed Description

This study will be organized in two consecutive steps:
  1. A first descriptive step that will consist of a retrospective analysis of virtual consultation records of patients with RA during the pandemic and lockdown period in order to analyze on which criteria the patients were assessed and followed during this period.

  2. The second step will consist in evaluating the interest of the systematic use in virtual consultation of a patient reported outcome (PRO), the RAID (Rheumatoid Arthritis Impact of Disease) questionnaire; and analyze how its results influence the rheumatologist decision-making.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of Rheumatoid Arthritis at the Time of Telemedicine
Actual Study Start Date :
Nov 30, 2021
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients with rheumatoid arthritis

Patients seen in virtual consultation

Other: Rheumatoid Arthritis Impact of Disease questionnaire
Rheumatoid Arthritis Impact of Disease questionnaire

Outcome Measures

Primary Outcome Measures

  1. Rate of face to face consultation, hospitalization and therapeutic modifications [Inclusion]

    The primary outcome will be the rate of face to face consultation, hospitalization and therapeutic modifications decided by the rheumatologist during the virtual consultation

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria

  • Follow-up in the rheumatology department of Cochin Hospital

  • Affiliated with a social security scheme

  • Non-opposition to participating in the study

  • Patients with a valid email address (registration to the virtual consultation system)

Exclusion Criteria:
  • Opposition to participate to this research

  • Inability to understand or speak French

  • Patient under tutor or curator ship

  • patients under medical state help

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rheumatology Department, Cochin Hospital Paris IDF France 75014

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Jérôme AVOUAC, MD, PhD, Assistance Publique - Hôpitaux de Paris

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT05124782
Other Study ID Numbers:
  • APHP210550
First Posted:
Nov 18, 2021
Last Update Posted:
Mar 2, 2022
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 2, 2022